TLDR
- Veea Systems stock surged nearly 90% Tuesday after signing a term sheet to merge with NovaGen Group B.V.
- The combined entity will be called NovaGen Health Networks, linking edge AI with health data for regenerative care.
- GeoNova Capital signed a term sheet to invest $10 million into the new combined company.
- The companies value the new firm at approximately $750 million, based on their own plans and a third-party review.
- Trading volume exploded to over 41 million shares, compared to a three-month daily average of around 150,000.
Veea Systems stock was trading up over 172% at $6.23 Tuesday, following an already strong 46.79% gain on Monday. The move came after the edge-computing company announced plans to merge with NovaGen Group B.V. in a deal that would create a new connected health platform.
The two companies have signed a term sheet and plan to finalize the deal within the next few weeks.
The combined company will operate under the name NovaGen Health Networks. It will bring together Veea’s edge-computing, cybersecurity, and AI infrastructure with NovaGen’s regenerative medicine software.
The platform will run on Veea’s VeeaONE system. It will pull together health records, wearables, sensors, and biometric data into a single long-term health profile stored and processed on local devices.
Patients will control who can access their data, which is a key selling point the companies are pushing.
The first sites are expected to go live at NovaGen clinics and partner hospitals in Q4 2026. The initial phase will focus on AI health tools and record sharing.
GeoNova Capital Commits $10 Million
GeoNova Capital has signed a term sheet to come in as the lead investor, putting $10 million into the new entity to fund commercial development.
The companies placed the value of the combined firm at around $750 million, based on internal plans and a third-party valuation. Neither the merger nor the GeoNova investment is finalized yet.
Veea CEO Allen Salmasi said the setup puts AI and data tools close to where care actually happens, while giving users more control over their personal health information.
NovaGen CEO Diederik van der Reijt said the network creates a path to find and evaluate candidates for their therapies, and could start that connection before a patient ever walks into a clinic.
Volume Tells the Story
Tuesday’s move brought massive trading activity. More than 41 million VEEA shares changed hands, against a three-month average daily volume of around 150,000.
That is roughly 270 times the normal daily volume.
Despite Tuesday’s surge, the stock is still down 82.03% year-to-date and has dropped 79.13% over the past 12 months.
Veea has limited analyst coverage. The Overall Consensus from TipRanks shows a Neutral rating, based on eight Bearish, six Neutral, and eight Bullish technical indicators.
The company has said it will continue operating with its existing clients and markets alongside the new venture.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
